Search

Search Constraints

You searched for: Author/Creator Fields, Paul

Search Results

3. A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphoma. Issue 9 (September 2013)

5. British HIV Association guidelines for HIV‐associated malignancies 2014. (March 2014)

6. Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study. Issue 6 (June 2021)

7. Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial. Issue 5 (May 2019)

10. Impact of age on the toxicity of immune checkpoint inhibition. Issue 2 (8th October 2020)